Trimetazidine dihydrochloride is mainly used to treat angina pectoris (chest pain due to heart ischemia). It works by improving cellular energy metabolism in heart muscle cells, helping them better tolerate low oxygen conditions. It helps reduce the frequency and severity of angina attacks without affecting heart rate or blood pressure. It is also used to improve symptoms in some cases of vertigo and tinnitus related to inner ear disorders. It is grouped under the following drug class(es): Antianginals. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Kyurinett, Adexor, Lubomail, Vastarel and Yosimilon. Its PubChem CID is 83201.
Trimetazidine dihydrochloride
| CAS No | 13171-25-0 |
|---|---|
| Molecular Formula | C14H24Cl2N2O3 |
| Molecular Weight | 339.3 g/mol |
| Synonyms | 1-[(2,3,4-trimethoxyphenyl)methyl]piperazine;dihydrochloride |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Trimetazidine dihydrochloride is mainly used to treat angina pectoris (chest pain due to heart ischemia). It works by improving cellular energy metabolism in heart muscle cells, helping them better tolerate low oxygen conditions.
The listed CAS number is 13171-25-0.
The listed molecular formula is C14H24Cl2N2O3.
The listed molecular weight is 339.3 g/mol.
1-[(2,3,4-trimethoxyphenyl)methyl]piperazine;dihydrochloride.
The source lists Kyurinett, Adexor, Lubomail, Vastarel and Yosimilon.